These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9305372)

  • 41. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
    Kane I; Ragucci D; Shatat IF; Bussel J; Kalpatthi R
    Br J Haematol; 2010 Apr; 149(1):79-83. PubMed ID: 20096011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 44. New treatments for multiple sclerosis: a clinical perspective.
    Thompson AJ; Noseworthy JH
    Curr Opin Neurol; 1996 Jun; 9(3):187-98. PubMed ID: 8839609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and tolerability of an intravenous immune globulin at various concentrations in 5% dextrose injection or sterile water for injection.
    Miller KB; Schenkein DP; Wasserman RL
    Clin Pharm; 1992 Jul; 11(7):628-31. PubMed ID: 1617914
    [No Abstract]   [Full Text] [Related]  

  • 47. Intravenous immunoglobulins, pregnancy and multiple sclerosis.
    Confavreux C
    J Neurol; 2004 Sep; 251(9):1138-9. PubMed ID: 15372260
    [No Abstract]   [Full Text] [Related]  

  • 48. Recommended timing of routine measles immunization for children who have recently received immune globulin preparations. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1994 Apr; 93(4):682-5. PubMed ID: 8134232
    [No Abstract]   [Full Text] [Related]  

  • 49. Practical aspects of immunoglobulin replacement.
    Ballow M
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):299-303. PubMed ID: 28958372
    [No Abstract]   [Full Text] [Related]  

  • 50. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Fanaroff AA; Korones SB; Wright LL; Wright EC; Poland RL; Bauer CB; Tyson JE; Philips JB; Edwards W; Lucey JF
    N Engl J Med; 1994 Apr; 330(16):1107-13. PubMed ID: 8133853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration.
    Arfi AM; Kouatli A; Al-Ata J; Arif H; Syed S
    Indian Heart J; 2005; 57(3):261-4. PubMed ID: 16196187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
    Humle Jorgensen S; Sorensen PS
    J Neurol Sci; 2005 Jun; 233(1-2):61-5. PubMed ID: 15949496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Summary of the ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
    Am J Hosp Pharm; 1992 Mar; 49(3):652-4. PubMed ID: 1598949
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis.
    Boletis JN; Ioannidis JP; Boki KA; Moutsopoulos HM
    Lancet; 1999 Aug; 354(9178):569-70. PubMed ID: 10470708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous immunoglobulins and mucous membrane pemphigoid.
    Mignogna MD; Leuci S; Piscopo R; Bonovolontà G
    Ophthalmology; 2008 Apr; 115(4):752-752.e1. PubMed ID: 18387410
    [No Abstract]   [Full Text] [Related]  

  • 56. The assessment and management of primary antibody deficiency.
    Empson M; Sinclair J; O'Donnell J; Ameratunga R; Fitzharris P; Steele R;
    N Z Med J; 2004 Jun; 117(1195):U914. PubMed ID: 15282626
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
    Kazatchkine MD; Kaveri SV
    N Engl J Med; 2001 Sep; 345(10):747-55. PubMed ID: 11547745
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.
    Simoes J; Sciascia S; Camara I; Baldovino S; Karim Y; Roccatello D; Cuadrado MJ
    J Clin Rheumatol; 2015 Jan; 21(1):35-7. PubMed ID: 25539433
    [No Abstract]   [Full Text] [Related]  

  • 59. How should we proceed with disease-modifying treatments for multiple sclerosis?
    Andersson PB; Waubant E; Goodkin DE
    Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravenous immunoglobulin therapy for resistant ocular Behçet's disease.
    Seider N; Beiran I; Scharf J; Miller B
    Br J Ophthalmol; 2001 Nov; 85(11):1287-8. PubMed ID: 11673289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.